-- 
Biomerieux, HSBC, Rhodia, Rio Tinto: Europe Equity Preview

-- B y   N i k o l a j   G a m m e l t o f t
-- 
2011-09-07T04:00:04Z

-- http://www.bloomberg.com/news/2011-09-06/biomerieux-hsbc-rhodia-rio-tinto-europe-equity-preview.html
Shares of the following companies
may have unusual moves in European trading. Stock symbols are in
parentheses.  The Stoxx  Europe  600 Index fell 0.7 percent to 221.98. The
Stoxx 50 Index slipped 0.8 percent to 2,091.50. The Euro Stoxx
50 Index, a benchmark measure for nations using the euro, lost
1.3 percent to 2,080.10.  Biomerieux (BIM)  SA: The maker of tests for HIV and
hepatitis said net income rose 3.7 percent to 75 million euros
($105 million) in the first half and operating income climbed
8.6 percent to 119 million euros. The company expects organic
sales growth of about 5 percent this year. The shares fell 0.6
percent to 72 euros.  HSBC Holdings Plc (HSBA)  : Europe’s largest bank is in
talks on a possible sale of the full-service investment advisory
division of its Canadian retail brokerage. The stock advanced
0.9 percent to 509.2 pence.  Rhodia SA (RHA)  :  Fitch Ratings  raised the chemicals
company’s debt to BBB+ from BB and assigned a stable outlook.
The shares gained 0.1 percent to 31.54 euros.  Rio Tinto Plc (RIO)  :  Zimbabwe  has reached an agreement
with  Rio Tinto  Group’s Murowa diamond mine and 45 other mining
companies regarding its effort to increase black ownership of
the industry. The shares climbed 1.7 percent to 3,549 pence.  Sanofi (SAN FP): Chief Executive Officer Chris Viehbacher
said he is comfortable with the drugmaker’s current business mix
and said he is optimistic about the prospects for the company
going into the 2012-2015 period. The shares climbed 1.7 percent
to 48.88 euros.  Vallares Plc (VLRS LN): The investment vehicle led by BP
Plc’s former Chief Executive Officer  Tony Hayward  plans to buy
into Turkish oil explorer Genel Enerji, a person familiar with
the matter said. The shares rose 0.7 percent to 995 pence.  To contact the reporter on this story:
Nikolaj Gammeltoft in New York at 
 ngammeltoft@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net  